# Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer

Source: https://onco.cc/trials/nct00002881/  
OnCo record `nct00002881` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Flutamide, Goserelin / leuprolide and Leuprolide in Prostate cancer, run by Eastern Cooperative Oncology Group, completed.

## Summary

Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer is a phase 3 interventional study registered as NCT00002881 by Eastern Cooperative Oncology Group, started 1996-10 and reaching its primary completion in 1998-04. Interventions recorded: flutamide, goserelin acetate, leuprolide acetate, suramin, therapeutic hydrocortisone, orchiectomy. Conditions recorded: Prostate Cancer.

Linked to the drug Flutamide because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT00002881
- Phase: 3
- Setting: PHASE III TRIAL OF ORCHIECTOMY/LHRH ANALOG + FLUTAMIDE + SURAMIN + HYDROCORTISONE VS ORCHIECTOMY/LHRH ANALOG + FLUTAMIDE IN PATIENTS WITH METASTATIC PROSTATE CANCER
- Sponsor: Eastern Cooperative Oncology Group

## Sources

- ClinicalTrials.gov NCT00002881: https://clinicaltrials.gov/study/NCT00002881

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- drugs: [Flutamide](https://onco.cc/drugs/flutamide/), [Goserelin / leuprolide (ovarian function suppression)](https://onco.cc/drugs/goserelin/), [Leuprolide (leuprorelin) and GnRH agonists](https://onco.cc/drugs/leuprolide/)

---
JSON: https://onco.cc/api/v1/entities/nct00002881.json